beta-carboline-3-carboxylic acid ethyl ester has been researched along with s 135 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eigyo, M; Kawasaki, K; Matsushita, A; Murata, S; Sasatani, T; Shindo, H; Takada, S | 1 |
| Kawasaki, K; Matsushita, A; Satoh, M; Yasui, M | 1 |
2 other study(ies) available for beta-carboline-3-carboxylic acid ethyl ester and s 135
| Article | Year |
|---|---|
A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors.
Topics: Administration, Oral; Animals; Anticonvulsants; Indicators and Reagents; Male; Mice; Pentylenetetrazole; Pyrazoles; Quinolines; Receptors, GABA-A; Seizures; Thiophenes | 1987 |
Benzodiazepine inverse agonists augment long-term potentiation in CA1 and CA3 of guinea pig hippocampal slices.
Topics: Animals; Benzodiazepines; Carbolines; Electric Stimulation; Evoked Potentials; Flumazenil; Guinea Pigs; Hippocampus; In Vitro Techniques; Male; Neuronal Plasticity; Psychotropic Drugs; Pyrazoles; Quinolones | 1993 |